日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A bespoke target selection tool to guide biomarker discovery in tubo-ovarian cancer

一种用于指导输卵管卵巢癌生物标志物发现的定制靶点选择工具

Beirne, James P; Gilmore, Alan; McInerney, Caitríona E; Roddy, Aideen; Glenn McCluggage, W; Harley, Ian J G; Abdullah Alvi, M; Prise, Kevin M; McArt, Darragh G; Mullan, Paul B

Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes

卵巢癌液体活检:在隐形杀手发作前将其捕获

Feeney, Laura; Harley, Ian Jg; McCluggage, W Glenn; Mullan, Paul B; Beirne, James P

Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

糖皮质激素受体表达可预测三阴性乳腺癌患者接受不含紫杉烷类药物、以蒽环类药物为基础的治疗后的良好预后

Elkashif, Ahmed; Bingham, Victoria; Haddock, Paula; Humphries, Matthew P; McQuaid, Stephen; Mullan, Paul B; McCarthy, Helen O; Buckley, Niamh E

NUP98 - a novel predictor of response to anthracycline-based chemotherapy in triple negative breast cancer

NUP98——一种预测三阴性乳腺癌患者对蒽环类药物化疗反应的新型指标

Mullan, Paul B; Bingham, Victoria; Haddock, Paula; Irwin, Gareth W; Kay, Elaine; McQuaid, Stephen; Buckley, Niamh E

Automated Tumour Recognition and Digital Pathology Scoring Unravels New Role for PD-L1 in Predicting Good Outcome in ER-/HER2+ Breast Cancer

自动化肿瘤识别和数字病理评分揭示了PD-L1在预测ER-/HER2+乳腺癌良好预后中的新作用

Humphries, Matthew P; Hynes, Sean; Bingham, Victoria; Cougot, Delphine; James, Jacqueline; Patel-Socha, Farah; Parkes, Eileen E; Blayney, Jaine K; O'Rorke, Michael A; Irwin, Gareth W; McArt, Darragh G; Kennedy, Richard D; Mullan, Paul B; McQuaid, Stephen; Salto-Tellez, Manuel; Buckley, Niamh E

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

乳腺癌中S期特异性DNA损伤激活STING依赖性先天免疫信号通路

Parkes, Eileen E; Walker, Steven M; Taggart, Laura E; McCabe, Nuala; Knight, Laura A; Wilkinson, Richard; McCloskey, Karen D; Buckley, Niamh E; Savage, Kienan I; Salto-Tellez, Manuel; McQuaid, Stephen; Harte, Mary T; Mullan, Paul B; Harkin, D Paul; Kennedy, Richard D

Thromboxane A2 receptor (TBXA2R) is a potent survival factor for triple negative breast cancers (TNBCs)

血栓素A2受体(TBXA2R)是三阴性乳腺癌(TNBC)的强效生存因子。

Orr, Katy; Buckley, Niamh E; Haddock, Paula; James, Colin; Parent, Jean-Luc; McQuaid, Stephen; Mullan, Paul B

PICan: An integromics framework for dynamic cancer biomarker discovery

PICan:用于动态癌症生物标志物发现的整合组学框架

McArt, Darragh G; Blayney, Jaine K; Boyle, David P; Irwin, Gareth W; Moran, Michael; Hutchinson, Ryan A; Bankhead, Peter; Kieran, Declan; Wang, Yinhai; Dunne, Philip D; Kennedy, Richard D; Mullan, Paul B; Harkin, D Paul; Catherwood, Mark A; James, Jacqueline A; Salto-Tellez, Manuel; Hamilton, Peter W

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention

非侵袭性乳腺病变的分子分型及其在个体化治疗和化学预防中的应用

Buckley, Niamh; Boyle, David; McArt, Darragh; Irwin, Gareth; Harkin, D Paul; Lioe, Tong; McQuaid, Stephen; James, Jacqueline A; Maxwell, Perry; Hamilton, Peter; Mullan, Paul B; Salto-Tellez, Manuel

TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

TBX2 抑制 CST6,导致不受控制的 legumain 活性,从而维持乳腺癌细胞增殖:一种具有治疗机会的新型癌症选择性靶向通路

D'Costa Zenobia C, Higgins Catherine, Ong Chee Wee, Irwin Gareth W, Boyle David, McArt Darragh G, McCloskey Karen, Buckley Niamh E, Crawford Nyree T, Thiagarajan Lalitha, Murray James T, Kennedy Richard D, Mulligan Karl A, Harkin D Paul, Waugh David J J, Scott Chris J, Salto-Tellez Manuel, Williams Richard, Mullan Paul B